US Patent 9868729 Inhibitors of protein kinases

Patent 9868729 was granted and assigned to Portola Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Portola Pharmaceuticals

Current Assignee

Portola Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9868729

Patent Inventor Names

Shawn M. Bauer0

Anjali Pandey0

Date of Patent

January 16, 2018

Patent Application Number

14561821

Date Filed

December 5, 2014

Patent Citations Received

‌

US Patent 11713309 Solid forms of Cerdulatinib

‌

US Patent 11661414 Solid forms of Cerdulatinib

Patent Primary Examiner

‌

Marcos Sznaidman

Patent abstract

Provided are methods of treating inflammatory disorders, autoimmune disorders, or a hematological malignancies using compounds of formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9868729 Inhibitors of protein kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API